AZ-6102 is primarily utilized in the field of biomedical research, particularly in the study of cancer and other diseases. It functions as a potent and selective inhibitor of certain enzymes or proteins that play a critical role in cellular signaling pathways. By targeting these specific molecules, AZ-6102 helps researchers understand the mechanisms of disease progression and identify potential therapeutic strategies. Its application is especially relevant in preclinical studies, where it is used to evaluate the efficacy of inhibiting specific targets in cancer models. This compound aids in the development of novel drug candidates by providing insights into the biological pathways involved in tumor growth and survival. Additionally, AZ-6102 may be employed in high-throughput screening assays to discover new compounds with similar or improved inhibitory properties. Its role in advancing personalized medicine and targeted therapies makes it a valuable tool in modern drug discovery and development.